BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 31148582)

  • 21. Diagnostic and prognostic value of serum thioredoxin and DJ-1 in non-small cell lung carcinoma patients.
    Fan J; Yu H; Lv Y; Yin L
    Tumour Biol; 2016 Feb; 37(2):1949-58. PubMed ID: 26334622
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ratio of C-Reactive Protein/Albumin is An Inflammatory Prognostic Score for Predicting Overall Survival of Patients with Small-cell Lung Cancer.
    Zhou T; Zhan J; Hong S; Hu Z; Fang W; Qin T; Ma Y; Yang Y; He X; Zhao Y; Huang Y; Zhao H; Zhang L
    Sci Rep; 2015 Jun; 5():10481. PubMed ID: 26084991
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic value of C-reactive protein/albumin ratio for patients with hypopharyngeal and laryngeal cancer undergoing invasive surgery involving laryngectomy.
    Kuboki A; Kanaya H; Nakayama T; Konno W; Goto K; Nakajima I; Kashiwagi T; Hirabayashi H; Haruna SI
    Head Neck; 2019 May; 41(5):1342-1350. PubMed ID: 30552844
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Ratio of C-Reactive Protein/Albumin is a Novel Inflammatory Predictor of Overall Survival in Cisplatin-Based Treated Patients with Metastatic Nasopharyngeal Carcinoma.
    Sun P; Chen C; Xia Y; Bi X; Liu P; Zhang F; Yang H; An X; Jiang W; Wang F
    Dis Markers; 2017; 2017():6570808. PubMed ID: 28676731
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Predictive Value of Preoperative High-Sensitive C-Reactive Protein/Albumin Ratio in Systemic Inflammatory Response Syndrome After Percutaneous Nephrolithotomy.
    Xu H; Hu L; Wei X; Niu J; Gao Y; He J; Hou J
    J Endourol; 2019 Jan; 33(1):1-8. PubMed ID: 30430854
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prospective evaluation of C-reactive protein, smoking and lung cancer death in the Third National Health and Nutrition Examination Survey.
    Bittoni MA; Focht BC; Clinton SK; Buckworth J; Harris RE
    Int J Oncol; 2015 Oct; 47(4):1537-44. PubMed ID: 26323323
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The prognostic value of C-reactive protein/albumin ratio in nasopharyngeal carcinoma: a meta-analysis.
    Gao N; Yang RN; Meng Z; Wang WH
    Biosci Rep; 2018 Dec; 38(6):. PubMed ID: 30352836
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Circulating C-reactive protein increases lung cancer risk: Results from a prospective cohort of UK Biobank.
    Ji M; Du L; Ma Z; Xie J; Huang Y; Wei X; Jiang X; Xu J; Yin R; Wang Y; Dai J; Jin G; Xu L; Zhu C; Hu Z; Ma H; Zhu M; Shen H
    Int J Cancer; 2022 Jan; 150(1):47-55. PubMed ID: 34449869
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Baseline C-reactive protein level predicts survival of early-stage lung cancer: evidence from a systematic review and meta-analysis.
    Leuzzi G; Galeone C; Gisabella M; Duranti L; Taverna F; Suatoni P; Morelli D; Pastorino U
    Tumori; 2016 Oct; 102(5):441-449. PubMed ID: 27292573
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A Novel Inflammation-Based Prognostic Score, the C-Reactive Protein/Albumin Ratio Predicts the Prognosis of Patients with Operable Esophageal Squamous Cell Carcinoma.
    Xu XL; Yu HQ; Hu W; Song Q; Mao WM
    PLoS One; 2015; 10(9):e0138657. PubMed ID: 26390126
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The relationship between Glasgow Prognostic Score and serum tumor markers in patients with advanced non-small cell lung cancer.
    Jiang AG; Chen HL; Lu HY
    BMC Cancer; 2015 May; 15():386. PubMed ID: 25956656
    [TBL] [Abstract][Full Text] [Related]  

  • 32. C-reactive protein/albumin ratio is a poor prognostic factor of esophagogastric junction and upper gastric cancer.
    Kudou K; Saeki H; Nakashima Y; Kamori T; Kawazoe T; Haruta Y; Fujimoto Y; Matsuoka H; Sasaki S; Jogo T; Hirose K; Hu Q; Tsuda Y; Kimura K; Ando K; Oki E; Ikeda T; Maehara Y
    J Gastroenterol Hepatol; 2019 Feb; 34(2):355-363. PubMed ID: 30119141
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High-density lipoprotein cholesterol is a favorable prognostic factor and negatively correlated with C-reactive protein level in non-small cell lung carcinoma.
    Chi PD; Liu W; Chen H; Zhang JP; Lin Y; Zheng X; Liu W; Dai S
    PLoS One; 2014; 9(3):e91080. PubMed ID: 24625581
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Preoperative C-reactive protein/albumin ratio predicts the prognosis of patients with resectable pancreatic cancer].
    Luo BY; Yang Y; Duan YF; Cai HH; An Y; Sun DL
    Zhonghua Wai Ke Za Zhi; 2018 Sep; 56(9):712-717. PubMed ID: 30157579
    [No Abstract]   [Full Text] [Related]  

  • 35. Prognostic significance of pre-resection albumin/fibrinogen ratio in patients with non-small cell lung cancer: A propensity score matching analysis.
    Chen S; Yan H; Du J; Li J; Shen B; Ying H; Zhang Y; Chen S
    Clin Chim Acta; 2018 Jul; 482():203-208. PubMed ID: 29653085
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A novel inflammation-based prognostic score in esophageal squamous cell carcinoma: the C-reactive protein/albumin ratio.
    Wei XL; Wang FH; Zhang DS; Qiu MZ; Ren C; Jin Y; Zhou YX; Wang DS; He MM; Bai L; Wang F; Luo HY; Li YH; Xu RH
    BMC Cancer; 2015 May; 15():350. PubMed ID: 25934640
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Does C reactive protein/Albumin ratio have prognostic value in patients with COVID-19.
    Kalabin A; Mani VR; Valdivieso SC; Donaldson B
    J Infect Dev Ctries; 2021 Aug; 15(8):1086-1093. PubMed ID: 34516415
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Influence of the Preoperative C-Reactive Protein-to-Albumin Ratio on Survival and Recurrence in Patients With Esophageal Cancer.
    Tamagawa H; Aoyama T; Tamagawa A; Komori K; Maezawa Y; Kano K; Murakawa M; Atsumi Y; Hara K; Kazama K; Numata M; Oshima T; Yukawa N; Masuda M; Rino Y
    Anticancer Res; 2020 Apr; 40(4):2365-2371. PubMed ID: 32234939
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A laboratory prognostic index model for patients with advanced non-small cell lung cancer.
    Ulas A; Turkoz FP; Silay K; Tokluoglu S; Avci N; Oksuzoglu B; Alkis N
    PLoS One; 2014; 9(12):e114471. PubMed ID: 25474743
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of C-reactive protein/albumin ratio on prognosis in advanced non-small-cell lung cancer.
    Ni XF; Wu J; Ji M; Shao YJ; Xu B; Jiang JT; Wu CP
    Asia Pac J Clin Oncol; 2018 Dec; 14(6):402-409. PubMed ID: 30178541
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.